Normal View Dyslexic View

A tribute to Paul Sugarbaker: the father of cytoreductive surgery

Aditi Bhatt MS, MCh

Department of Surgical Oncology, Shalby Cancer and Research Institute, Ahmedabad, India

Brendan J. Moran MD

Peritoneal malignancy unit, Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK

Marcello Deraco MD

Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Naoual Bakrin MD PhD

Department of Surgical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

Joel Baumgartner MD

Department of Surgical Oncology, UC San Diego Health, La Jolia, CA, USA

Vahan Kepenekian MD, PhD

Department of Surgical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

Alvaro Arjona Sanchez MD

Department of Surgical Oncology, Pancreatic Surgery. Liver and Pancreas Transplantation, University hospital, Reina Sofia, Cordoba, Spain

Vivek Sukumar MS, MCh

Department of Surgical Oncology, Specialty Surgical Oncology Hospital, Mumbai, India

Kiran Turaga MD, MPH

Department of Surgical Oncology, Yale Medical Centre, New Haven, Connecticut, USA

Laurent Villeneuve MBE, PhD

Clinical Research and Epidemiological Unit, Public Health Department, Hospices Civils de Lyon, Lyon , France

Shigeki Kusamura MD, PhD

Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Olivier Glehen MD, PhD

Department of Surgical Oncology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

1 July 2025
Guest blog General
BJSA
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Nearly thirty years ago Paul Sugarbaker first published the classification and description of the techniques of peritonectomy procedures and organ resections as part of cytoreductive surgery1. Since then, Paul Sugarbaker has published numerous manuscripts, books and book chapters and produced videos on peritonectomy procedures. Some of these have been improvisations of the previous descriptions while others have been descriptions of new peritonectomy procedures that he had devised2,3,4. The description of the hepatic bridge and the clearance of the peritoneum in the tunnel created by it, clearance of peritoneal disease in an inguinal hernia, clearance of the foramen of Winslow and peritonectomy of the sub-pyloric space are some of the techniques published subsequently5,6,7,8,9,10. The most recent addition to the list was peritonectomy of the colonic mesentery published in 202111.
Paul Sugarbaker started working on the treatment of peritoneal malignancies in the early eighties and coined the term cytoreductive surgery for a surgical procedure that involved resection of all macroscopic tumor, including electrosurgical removal of the peritoneal tumor deposits, combined with administration of intraperitoneal chemotherapy12,13. The body of publications by Sugarbaker on peritonectomy procedures is the most comprehensive resource on these procedures in the literature, both in terms of the included procedures and the technical descriptions of these procedures. In 2016, Grey’s anatomy, for the first time, included a chapter on the anatomy of the peritoneum by Paul Sugarbaker14. Paul Sugarbaker has set the bar for the quality of operative surgical images published in these manuscripts. Cytoreductive surgery addresses different regions of the peritoneal cavity, and organ systems, and can appear disjointed and unstructured, especially in the setting of extensive peritoneal disease. The intraoperative images in his manuscripts are pristine, demonstrating each anatomical structure with great clarity15. This attention to detail underlines the importance of meticulous surgical technique, and the pursuit of perfection, which to those who have trained and worked with him, are his well-known hallmarks.
Paul Sugarbaker has over the years laid great emphasis on minute technical aspects of cytoreductive surgery, such as the incision and exposure of the peritoneal cavity, meticulous excision of previous surgical scars, use of high voltage electrocautery and copious lavage of the peritoneal cavity16,17,17. One of his most famous aphorisms ‘It’s what the surgeon does not see that kills the patient’ is a manuscript focusing on meticulous surgical technique to reduce peritoneal dissemination from colorectal primary tumors19. In current times, this aphorism incorporates , and underlines, the importance of ‘complete’ cytoreductive surgery which requires meticulous exploration of the abdominal cavity and identification and resection of all sites of disease. However, the original aphorism refers to another important concept that he introduced whereby he described the technique of centripetal surgery which involved starting the dissection far away from the tumor, and employing local peritonectomy procedures to contain the colorectal primary tumor19. While most of his work was on peritoneal metastases of gastrointestinal origin, the principles and concepts introduced by him are applicable to all surgical approaches for peritoneal malignancies. Another very significant Sugarbaker concept is that the peritoneum helps prevent retroperitoneal dissemination of peritoneal malignancy and is thus “the first line of defense” again peritoneal metastases20.
We have, in this short manuscript, attempted the daunting, near impossible, task of summarizing his main work on the principles and techniques of cytoreductive surgery. While not aiming to summarize the survival benefit of cytoreductive surgery, we also draw reference to his work in other fields, especially in the management of parastomal hernias. Many patients who require CRS need an intestinal stoma and live for many years with an excellent quality of life, long enough to develop parastomal hernias, a credit to the efficacy of the procedure for a disease that was a near fatal condition before the era of Paul Sugarbaker21. Arguably, Paul Sugarbaker has also described the most effective method of treatment of parastomal hernias, “the Sugarbaker repair” which is still widely used22,23.
His work on defining crucial imaging features of disease unresectability and the preclinical and clinical work on intraperitoneal chemotherapy would require separate manuscripts to summarize24,25,26,27.
In this issue of the journal, we publish the results of a consensus that aimed to revise the classification of peritonectomy procedures and anatomically define the boundaries of each peritonectomy procedure28,29,30. We involved Paul Sugarbaker in coining, and defining the most appropriate term for each procedure and selecting the most appropriate way to classify these procedures. The manuscripts carry many important remarks and insights from ‘the father of peritonectomy procedures’ and ‘the father of cytoreductive surgery’. As the second, third and fourth generation of peritoneal malignancy surgeons who have worked closely with him for varying periods of time, we hereby ‘render unto Caeser what belongs to Caeser’.
References
Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995 Jan;221(1):29-42. doi: 10.1097/00000658-199501000-00004. PMID: 7826158; PMCID: PMC1234492.
Sugarbaker PH. Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy. Transl Gastrointest Cancer 2013;2(2):54-74. doi: 10.3978/j.issn.2224-4778.2013.01.02
Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003 Jul;12(3):703-27, xiii. doi: 10.1016/s1055-3207(03)00048-6. PMID: 14567026.
Sugarbaker PH. An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Sugarbaker PH. eds. Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishers: Woodbury, CT, 2012.
Sugarbaker PH. Pont hepatique (hepatic bridge), an important anatomic structure in cytoreductive surgery. J Surg Oncol 2010;101:251-2.
Esquivel J, Sugarbaker PH. Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair. Eur J Surg Oncol. 2001 Feb;27(1):54-8. doi: 10.1053/ejso.2000.1031. PMID: 11237493.
Sugarbaker PH. Peritoneal tunnels: A site at risk for treatment failure when performing treatments for peritoneal metastases. A case series of 2 patients. Int J Surg Case Rep. 2019;61:309-312. doi: 10.1016/j.ijscr.2019.07.026. Epub 2019 Jul 19. PMID: 31399396; PMCID: PMC6718691.
Han SS, Sugarbaker PH. Kocher manoeuvre to facilitate cytoreduction within the foramen of Winslow. J Surg Oncol. 2017 Jun;115(7):788-790. doi: 10.1002/jso.24587. Epub 2017 May 5. PMID: 28475818.
Vazquez V de L, Sugarbaker PH. Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: a peritonectomy procedure. J Surg Oncol. 2003 Sep;84(1):45-9. doi: 10.1002/jso.10288. PMID: 12949991.
Sugarbaker PH. The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol 2002;28:443-6.
Sugarbaker PH. Peritonectomy of the colonic mesentery. Case report of a new surgical technology. Int J Surg Case Rep. 2021 Sep;86:106369. doi: 10.1016/j.ijscr.2021.106369. Epub 2021 Sep 6. PMID: 34507196; PMCID: PMC8433245.
Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg. 1989 May;32(3):164-70. PMID: 2713770.
Hallenbeck, P., Sanniez, C.K., Ryan, A.B., Neiley, B. and Sugarbaker, P.H. (1992), Cytoreductive Surgery and Intraperitoneal Chemotherapy. AORN Journal, 56: 50-52. https://doi.org/10.1016/S0001-2092(07)66649-6
Sugarbaker PH. Peritoneum and peritoneal cavity. (Chapter 63). In: Standring S, ed. Gray’s Anatomy. 41st ed. Churchill Livingston/Elsevier; 2015:1098–1110
Sugarbaker PH, Van der Speeten K. An overview of peritonectomy, visceral resection, and therapeutic laparoscopy for peritoneal surface malignancy. Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. 2nd edition. Cine-Med Publishing. 2017:17-46.
Sugarbaker PH. Circumferential cutaneous traction for exposure of the layers of the abdominal wall. Journal of Surgical Oncology. 2008 Nov 1;98(6):472-5.
Sugarbaker PH. Dissection by electrocautery with a ball tip. Journal of surgical oncology. 1994 Aug;56(4):246-8.
Sugarbaker PH, Van der Speeten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol 2016;7(1):29-44. doi: 10.3978/j.issn.2078-6891.2015.105
Sugarbaker PH. It's what the surgeon doesn't see that kills the patient. J Nippon Med Sch. 2000 Feb;67(1):5-8. doi: 10.1272/jnms.67.5. PMID: 10777840.
Sugarbaker PH. Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol. 2007 Feb 1;95(2):93-6. doi: 10.1002/jso.20676. PMID: 17262739.
Riss S, Chandrakumaran K, Dayal S, Cecil TD, Mohamed F, Moran BJ. Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking. Eur J Surg Oncol. 2015 Mar;41(3):392-5. doi: 10.1016/j.ejso.2014.09.002. Epub 2014 Sep 6. PMID: 25238953.
Sugarbaker PH. Peritoneal approach to prosthetic mesh repair of paraostomy hernias. Ann Surg. 1985;201:344–346. doi: 10.1097/00000658-198503000-00015.
Hansson BM, Morales-Conde S, Mussack T, Valdes J, Muysoms FE, Bleichrodt RP. The laparoscopic modified Sugarbaker technique is safe and has a low recurrence rate: a multicentre cohort study. Surg Endosc. 2013 Feb;27(2):494-500. doi: 10.1007/s00464-012-2464-4. Epub 2012 Oct 10. Erratum in: Surg Endosc. 2016 Sep;30(9):4160. doi: 10.1007/s00464-016-5079-3. PMID: 23052490; PMCID: PMC3580038.
Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer. 2005 Feb 15;103(4):839-49.
Van der Speeten K, Stuart OA, Sugarbaker PH. Cancer chemotherapy for peritoneal metastases: pharmacology and treatment. Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. 2nd edition. Cine-Med Publishing. 2017:47-82.
Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH. Pharmacokinetic study of perioperative intravenous Ifosfamide. International journal of surgical oncology. 2011;2011(1):185092.
Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer chemotherapy and pharmacology. 2003 Nov;52:405-10.
Bhatt A, Fotopoulou C, Moran BJ, Chi D, Stepanyan A, Baumgartner JM, et al. Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries. Br J Surg. 2025 May 31;112(6):znaf099. doi: 10.1093/bjs/znaf099. PMID: 40560096.
Bhatt A, Stepanyan A, Moran BJ, Chi D, Fotopoulou C, Baumgartner JM, et al. Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus. Br J Surg. 2025 May 31;112(6):znaf112. doi: 10.1093/bjs/znaf112. PMID: 40560098.
Glehen O, Bhatt A, Sugarbaker PH. Peritoneal surface malignancy: performing complete cytoreduction in occult peritoneal spaces is challenging. Br J Surg. 2025 May 31;112(6):znaf098. doi: 10.1093/bjs/znaf098. PMID: 40560099.
Info
Copied!